Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kilitch Drugs (India)'s Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹303 Mil. Therefore, Kilitch Drugs (India)'s EV-to-EBIT ratio for today is 16.69.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Kilitch Drugs (India)'s Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₹335 Mil. Therefore, Kilitch Drugs (India)'s EV-to-EBITDA ratio for today is 15.10.
Kilitch Drugs (India) Enterprise Value Historical Data
The historical data trend for Kilitch Drugs (India)'s Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kilitch Drugs (India)'s Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kilitch Drugs (India)'s Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Enterprise Value distribution charts can be found below:
* The bar in red indicates where Kilitch Drugs (India)'s Enterprise Value falls into.
Kilitch Drugs (India) Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Kilitch Drugs (India)'s Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kilitch Drugs (India) (NSE:KILITCH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Kilitch Drugs (India)'s current Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹303 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Kilitch Drugs (India)'s EV-to-EBITDA for today is:
Kilitch Drugs (India)'s current Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹335 Mil.
Kilitch Drugs (India)'s current Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,811 Mil.
Kilitch Drugs (India)'s current Enterprise Value is ₹5,058 Mil.
Kilitch Drugs (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kilitch Drugs (India) Enterprise Value Related Terms
Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:KILITCH has been successfully added to your 